Premium
Outcomes of long‐pulsed 1064 nm Nd:YAG laser treatment of basal cell carcinoma: A retrospective review
Author(s) -
Ahluwalia Jusleen,
Avram Mathew M.,
Ortiz Arisa E.
Publication year - 2019
Publication title -
lasers in surgery and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 112
eISSN - 1096-9101
pISSN - 0196-8092
DOI - 10.1002/lsm.23041
Subject(s) - medicine , laser , retrospective cohort study , basal cell carcinoma , nd:yag laser , adverse effect , surgery , basal cell , optics , physics
Background and Objective Recent prospective trials have supported treatment of nonfacial BCC with long‐pulsed 1064 nm Nd:YAG laser based on short‐term histologic clearance rates. Studies have yet to identify the long‐term clinical clearance rates of this specific laser therapy for BCC. Study Design/Material and Methods This is a retrospective review of BCC treated with long‐pulsed 1064 nm Nd:YAG laser, which have been clinically monitored for at least 6 months, to assess for recurrence and cosmetic outcomes of the treated area. Results 16 BCC lesions (11 subjects) treated with 1064 nm Nd:YAG laser were enrolled. Our analysis revealed 100% clearance rate in all subjects (16 of 16 BCC) treated with long‐pulsed Nd:YAG laser based on mean follow‐up of 9 months (range 6–15 months). Minimal scarring and no long‐term adverse events were noted. Conclusions This study supports the use of 1064 nm Nd:YAG laser as a therapeutic modality for BCC based on the absence of clinical recurrence upon a mean follow‐up of 9 months. As studies progress, we are beginning to observe a potential role for laser as an alternative to patients who refuse surgery, have multiple co‐morbidities, or decline non‐surgical therapies. Laser treatment with 1064 nm Nd:YAG is an evolving, promising story that we continue to investigate to optimize parameters. Lasers Surg. Med. 51:34–39, 2019. © 2018 Wiley Periodicals, Inc.